Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 10:40 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2065–2088 of 2,761 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: High Activity Clear all

Conditions: Neuropathic Pain From Lumbosacral Radiculopathy
Interventions: KLS-2031, Placebo; Drug · Other
Lead sponsor: Kolon Life Science; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Smoking
Interventions: Modified Natural American Spirit-Tan or Green cigarettes injected with labeled NNK; Combination Product
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 21 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Dysphagia
Interventions: RE-ACTIVE, PRO-ACTIVE EAT, PRO-ACTIVE EAT + EXERCISE; Behavioral
Lead sponsor: University Health Network, Toronto; Other
Eligibility: 18 Years and older
Enrollment: 952 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 10
States / cities: Miami, Florida • Orlando, Florida • Baltimore, Maryland + 7 more

Conditions: Stroke
Interventions: Exercise; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years to 85 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Medication Abuse, Harm Reduction, Opioid Overdose, Opioid Prescribing
Interventions: Naloxone Co-prescribing Clinical Decision Support (CDS); Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 12 Years to 89 Years
Enrollment: 114,272 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Oral Lesions
Interventions: High Resolution Microendoscope (HRME), Optical Mapping Scope, Proflavine hemisulfate; Device · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Staphylococcus Aureus, Carbapenem Resistant Gram Negative Bacteria
Interventions: Targeted gown and gloves use; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Alcohol Use Disorder
Interventions: High-density transcranial alternating current stimulation, Sham stimulation, Motivational interviewing; Device · Behavioral
Lead sponsor: The Mind Research Network; Other
Eligibility: 21 Years to 60 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Upper Back Pain
Interventions: Guaifenesin, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 5
States / cities: Fair Oaks, California • San Diego, California • Cincinnati, Ohio + 2 more

Conditions: Acute Pain, Postoperative
Interventions: LTG-001 High Dose, LTG-001 Mid Dose, LTG-001 Low Dose, Placebo, Suzetrigine; Drug · Other
Lead sponsor: Latigo Biotherapeutics; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Pneumonitis, SARS-CoV Infection
Interventions: GLS-1027, Placebo; Drug
Lead sponsor: GeneOne Life Science, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Child Behavior, Parent-Child Relations, Substance Use, Substance Abuse
Interventions: Filming Interactions to Nurture Development, The Healthy Toddler Program; Behavioral
Lead sponsor: University of Oregon; Other
Eligibility: Up to 50 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Logopenic Progressive Aphasia, Primary Progressive Aphasia
Interventions: High-definition active tDCS (HD-tDCS) + "Repeat After Me" (RAM) Treatment, Sham + "Repeat After Me" (RAM) Treatment; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder
Interventions: transcranial direct current stimulation, Sham stimulation; Device
Lead sponsor: Nathan Kline Institute for Psychiatric Research; Other
Eligibility: 18 Years to 55 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Orangeburg, New York

Conditions: Localized Prostate Cancer
Interventions: Aquablation Therapy, Active Surveillance; Device · Other
Lead sponsor: PROCEPT BioRobotics; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2038
U.S. locations: 27
States / cities: Chandler, Arizona • Los Angeles, California • Murrieta, California + 23 more

Conditions: Open Fracture Wounds
Interventions: Saline Solution, Soap solution, Gravity Flow Irrigation, Low Pressure Irrigation, High Pressure; Procedure
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 14 Years to 85 Years
Enrollment: 2,540 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 14
States / cities: Birmingham, Alabama • Orange, California • San Francisco, California + 11 more

Conditions: Hypertension
Interventions: Metoprolol succinate, Nebivolol, Forearm blood flow, Microneurography, Rhythmic handgrip exercise, Lower body negative pressure, Angiotensin II; Drug · Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: COVID-19, Oscillation and Lung Expansion
Interventions: MetaNeb® System; Device
Lead sponsor: Hill-Rom; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Atlanta, Georgia • Evanston, Illinois

Conditions: Benign Prostatic Hyperplasia (BPH)
Interventions: AQUABEAM System, Transurethral Resection of the Prostate (TURP); Device · Procedure
Lead sponsor: PROCEPT BioRobotics; Industry
Eligibility: 45 Years to 80 Years · Male only
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 12
States / cities: Birmingham, Alabama • La Mesa, California • Los Angeles, California + 9 more

Conditions: Breast Cancer, Colon Cancer, Lung Cancer, Skin Cancer, Rectum Cancer
Interventions: Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C), Active control comparator; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Phoenix, Arizona • Tucson, Arizona • Ann Arbor, Michigan

Conditions: Suicidal Ideation, Sleep Disturbance
Interventions: in-home sleep recording; Device
Lead sponsor: Palo Alto Veterans Institute for Research; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Caesarean Delivery
Interventions: TAP Block, Ropivacaine, Acetaminophen, Morphine; Drug
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 3
States / cities: Boston, Massachusetts • Lebanon, New Hampshire

Conditions: Tinnitus
Interventions: Oxytocin, Placebo nasal spray; Drug · Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy Subjects
Interventions: Placebo, E2609, Moxifloxacin; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: San Antonio, Texas

Search by objective public record fields.

Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

Metabolism of NNK in Japanese Americans

PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer

Exercise and Motor Learning After Stroke (Study #3)

Clinical Decision Support to Improve System Naloxone Co-prescribing

Precision Optical Guidance for Oral Biopsy

Targeted Gown and Glove Intervention in Nursing Homes

A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol

Exploratory Efficacy Study of Guaifenesin in Upper Back Pain

This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars

GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

A Scaleable Video Coaching Intervention for Opioid-using Mothers

Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA

Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways

WATER IV PCa (AS Sub-study)

Fluid Lavage of Open Wounds

Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients

Oscillation and Lung Expansion Therapy in Patients With COVID-19

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)

Adaptive Symptom Self-Management Immunotherapy Study

In-Home Sleep Monitoring to Detect Suicide Risk in Veterans

Comparison of Different Methods of Pain Control After Cesarean Section for Patients on Buprenorphine or Methadone

High Dose Oxytocin Nasal Spray for Treatment of Tinnitus

A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects